ES8600311A1 - Un procedimiento para la preparacion de derivados vinilacetamido oxacefalosporina - Google Patents

Un procedimiento para la preparacion de derivados vinilacetamido oxacefalosporina

Info

Publication number
ES8600311A1
ES8600311A1 ES526130A ES526130A ES8600311A1 ES 8600311 A1 ES8600311 A1 ES 8600311A1 ES 526130 A ES526130 A ES 526130A ES 526130 A ES526130 A ES 526130A ES 8600311 A1 ES8600311 A1 ES 8600311A1
Authority
ES
Spain
Prior art keywords
compound
represents hydrogen
carboxy
represent
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES526130A
Other languages
English (en)
Other versions
ES526130A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57172907A external-priority patent/JPS5962596A/ja
Priority claimed from JP58128116A external-priority patent/JPS6019791A/ja
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of ES8600311A1 publication Critical patent/ES8600311A1/es
Publication of ES526130A0 publication Critical patent/ES526130A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/535Organo-phosphoranes
    • C07F9/5352Phosphoranes containing the structure P=C-
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D505/00Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS DE VINILACETAMIDO DE OXACEFALOSPORINA.CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) O SU DERIVADO REACTIVO CON UN ACIDO CARBOXILICO DE FORMULA (III) O SU DERIVADO REACTIVO, EN PRESENCIA DE ACIDOS LIBRES, DERIVADOS DE ANHIDRIDO DE ACIDO DE DERIVADOS DE HALURO DE ACIDO, PARA OBTENER EL COMPUESTO DE FORMULA (I). SIENDO: U, H, CARBOXAMIDO, Y OTROS, O JUNTO CON V PUEDEN SER -S- O CH2S-; V ES H, HAL, U OTROS, O JUNTO CON W ES -(CH2)3CO-; W ES H, CARBONILO, Y OTROS; X ES HAL, TRIFLUORMETILO, Y OTROS; Y ES H, METAL LIGERO O GRUPO PROTECTOR DE ACIDO CARBOXILICO; Z ES UN ACILOXI O TIO-HETEROCICLO.SE UTILIZAN COMO ANTIBIOTICOS CONTRA BACTERIAS GRAM-POSITIVAS.
ES526130A 1982-09-30 1983-09-29 Un procedimiento para la preparacion de derivados vinilacetamido oxacefalosporina Granted ES526130A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP57172907A JPS5962596A (ja) 1982-09-30 1982-09-30 ビニルチオ化オキサセフアロスポリン誘導体
JP58128116A JPS6019791A (ja) 1983-07-13 1983-07-13 フルオロビニルチオオキサセフアロスポリン類

Publications (2)

Publication Number Publication Date
ES8600311A1 true ES8600311A1 (es) 1985-10-01
ES526130A0 ES526130A0 (es) 1985-10-01

Family

ID=26463879

Family Applications (1)

Application Number Title Priority Date Filing Date
ES526130A Granted ES526130A0 (es) 1982-09-30 1983-09-29 Un procedimiento para la preparacion de derivados vinilacetamido oxacefalosporina

Country Status (13)

Country Link
US (1) US4529721A (es)
EP (1) EP0107928B1 (es)
KR (1) KR900008552B1 (es)
AU (1) AU558772B2 (es)
CA (1) CA1219866A (es)
DE (1) DE3375141D1 (es)
DK (1) DK163000C (es)
ES (1) ES526130A0 (es)
FI (1) FI74015C (es)
GB (2) GB2127825B (es)
IE (1) IE55977B1 (es)
NO (1) NO168478C (es)
PH (2) PH20013A (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61130223A (ja) * 1984-11-28 1986-06-18 Shionogi & Co Ltd 抗菌性凍結乾燥製剤
KR960002856B1 (ko) * 1987-03-09 1996-02-27 오쓰까 세이야꾸 가부시끼가이샤 2-옥사-이소세펨 화합물, 이를 함유하는 조성물 및 이의 제조방법
US5126349A (en) * 1990-01-12 1992-06-30 The Dow Chemical Company Composition and use of substituted 3-thio-2-propynenitriles as an industrial antimicrobial
AU7226591A (en) * 1990-01-12 1991-08-21 Dow Chemical Company, The Composition and use of substituted 3-thio-2-propynenitriles as an industrial antimicrobial
US5198445A (en) * 1990-01-12 1993-03-30 The Dow Chemical Company Composition and use of substituted 3-thio-2-propynenitriles as industrial antimicrobials
US5157051A (en) * 1992-03-05 1992-10-20 The Dow Chemical Company Composition and use of 3-thiocyano-2-halo-2-propenenitriles as antimicrobial agents
US5155119A (en) * 1992-03-05 1992-10-13 The Dow Chemical Company 3-(2-pyridinylthio)-N-oxide, 2-halo-2-propenenitrile compounds useful as antimicrobials
US5206227A (en) * 1992-06-02 1993-04-27 The Dow Chemical Company Composition and use of phosphonic acid, (2-halo-2-cyanoethenyl)-dialkyl esters as antimicrobials
US5958462A (en) * 1997-05-23 1999-09-28 Mclean; Linsey Therapeutic bath salts and method of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1604738A (en) * 1977-07-28 1981-12-16 Yamanouchi Pharma Co Ltd 1,3-dithietane-2-carboxylic acid derivatives and the preparation thereof
DE2821639A1 (de) * 1978-05-18 1979-11-22 Hoechst Ag Neue thioenolaether, verfahren zu ihrer herstellung sowie ihre verwendung
GB2045233B (en) * 1979-03-23 1983-05-11 Erba Farmitalia Unsaturated 3-heterocyclylthiomethyl-7a-methoxy-7-acylamido-3-cephem-4-carboxylic acid derivatives
JPS5690088A (en) * 1979-11-02 1981-07-21 Meiji Seika Kaisha Ltd Novel cephalosporin analog compound
JPS56103185A (en) * 1980-01-22 1981-08-18 Shionogi & Co Ltd Malonamidoxa-dethia-cephem compound
IL63965A (en) * 1980-10-10 1985-01-31 Sparamedica Ag 7-(2-(2-amino-4-selenazoyl)acetamido)cephalosporin derivatives,and intermediates therefor,their preparation and pharmaceutical compositions containing them
FR2496666A1 (fr) * 1980-12-22 1982-06-25 Ici Pharma Nouveaux derives de cephalosporine et composition pharmaceutique les contenant

Also Published As

Publication number Publication date
GB8326244D0 (en) 1983-11-02
GB8601753D0 (en) 1986-02-26
DE3375141D1 (en) 1988-02-11
DK163000C (da) 1992-06-01
CA1219866A (en) 1987-03-31
DK426683D0 (da) 1983-09-19
IE55977B1 (en) 1991-03-13
NO168478B (no) 1991-11-18
US4529721A (en) 1985-07-16
AU1975283A (en) 1984-04-05
FI833348A0 (fi) 1983-09-20
FI74015B (fi) 1987-08-31
AU558772B2 (en) 1987-02-05
EP0107928A1 (en) 1984-05-09
PH20013A (en) 1986-08-28
KR840006252A (ko) 1984-11-22
PH20224A (en) 1986-10-23
ES526130A0 (es) 1985-10-01
DK426683A (da) 1984-03-31
GB2127825B (en) 1987-03-11
EP0107928B1 (en) 1988-01-07
KR900008552B1 (ko) 1990-11-24
FI74015C (fi) 1987-12-10
GB2168349B (en) 1987-03-11
NO168478C (no) 1992-02-26
GB2127825A (en) 1984-04-18
IE832310L (en) 1984-03-30
DK163000B (da) 1992-01-06
NO833521L (no) 1984-04-02
FI833348A (fi) 1984-03-31
GB2168349A (en) 1986-06-18

Similar Documents

Publication Publication Date Title
IL64905A (en) Process for the preparation of 2-penems,carbapenems,carbacephams,oxapenems,and azapenems,some novel such compounds and pharmaceutical compositions containing them
DE3069408D1 (en) 5-oxo- and 5-thioxoproline derivatives, process for their production and pharmaceutical compositions containing them
ES2000604A6 (es) Un procedimiento para preparar aril-piperidin esteres
ES8600311A1 (es) Un procedimiento para la preparacion de derivados vinilacetamido oxacefalosporina
IL89785A0 (en) Acyl derivatives,their manufacture and pharmaceutical compositions containing them
IE790630L (en) 2, 6-dialkoxybenzamido-pyrrolidines.
ES2121585T3 (es) Compuestos antibioticos de carbapenem.
ES8501748A1 (es) Un procedimiento para preparar derivados de benzamida
WO1989001330A3 (en) W-arylsulphonamidoalkanoic acids for treatment of thromboxane mediated diseases
JPS56128783A (en) Beta-lactam antibacterial compound, its manufacture and its medicinal compound
ATE8257T1 (de) Verfahren zur herstellung von 4-chinolinonen.
ES2009925A6 (es) Procedimiento para preparar nuevos tetrahidrofuranos y tetrahidrotiofenos.
DE69232776D1 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenverbindungen in diesem Verfahren
EP0049999A3 (en) Cyclic compounds and their preparation and use
KR940009189A (ko) 페넴 화합물
IE820238L (en) Carbapenem derivatives
ES2001440A6 (es) Procedimiento de prepararion de nuevos derivados de catecol
NO883297D0 (no) Substituerte carbapenem-3-karboksylsyrederivater.
AR241434A1 (es) Procedimiento para la preparacion de 3-(piperidinil)-1h-indazoles.
AU5977980A (en) Aminodeoxyclavulanic acids
EP0338494A3 (de) 3-Anilino-2-hydroxycarbonyl-4-thiophenessigsäuren
EP0338493A3 (de) Tetrahydro-4-phenylimino-3-thiophenessigsäuren

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519